合成路线1
该中间体在本合成路线中的序号:
(XXVI) The reaction of the dianhydride (II) with benzyl carbazate (E) gives the bis(benzyloxycarbonylhydrazide) compound (XXI), which by an enzymatic treatment with an aminopeptidase from Streptomyces sapporonensis yields the monohydrazide (XXII). The protection of (XXII) with benzyloxycarbonyl chloride (B) affords the protected monohydrazide (XXIII), which is cyclized by treatment with SOCl2 giving the monocarboxy anhydride (XXIV). Hydrolysis of (XXIV) with HCl yields amino acid (XXV), which is condensed with glycine (XXVI) to afford the dipeptide (XXVII). The condensation of (XXVII) with (X) gives the protected FK-156 (XXVIII), which is debenzylated by hydrogenolysis with H2 over Pd/C in methanol-acetic acid affording FK-156 still protected with an acetoxy and a hydrazine group (XXIX).
【1】
Hemmi, K.; Nakaguchi, O.; Hashimoto, M.; Taleno, H.; Kitaura, Y.; Okada, S.; An efficient method for selective amino acid protection of meso-2,2'-diaminocarboxylic acid: An improved synthesis of FK-156. Tetrahedron Lett 1982, 23, 6, 693-696.
|
【2】
Imanaka, H.; Nakahaa, K.; Gotoh, T.; Aoki, H.; Iwami, M.; Studies on a new immunoactive peptide, FK-156. I. Taxonomy of the producing strains. J Antibiot 1982, 35, 10, 1280-85.
|
【3】
Okada, S.; Hemmi, K.; Takano, H.; Hashimoto, M.; Nakaguchi, O.; Kitaura, Y.; Aratani, M.; Miyazaki, Y.; Studies of a new immunoactive peptide, FK-156. IV. Synthesis od FK-156 and its geometric isomer. J Antibiot 1982, 35, 10, 1300-11.
|
【4】
Gotoh, T.; Imoraka, H.; Nakahara, K.; Tanaka, H.; Uchida, I.; Kawai, Y.; Studies on a new immunoactive peptide, FK-156. III. Structure elucidation. J Antibiot 1982, 35, 10, 1293-99.
|
【5】
Okahara, M.; Nakahara, K.; Gotoh, T.; Hashimoto, M..; Kino, T.; Aoki, H.; Imanaka, H.; Kohsaka, M.; Nishiura, T.; Kuroda, Y.; Studies on a new immunoactive peptide, FK-156. II. Fermentation, extraction and chemical and biological charaterization. J Antibiot 1982, 35, 10, 1286-92. |
【6】
Kitaura, Y.; Nakaguchi, O.; Hemmi, K.; Aratani, M.; Takeno, H.; Okada, S.; Tanaka, H.; Hashimoto, M. (Fujisawa Pharmaceutical Co., Ltd.); New peptides, processes for their preparation and pharmaceutical compsns. containing them. EP 0027260 .
|
【7】
Kitaura, Y.; Nakaguchi, O.; Hemmi, K. (Fujisawa Pharmaceutical Co., Ltd.); New lactyl tetrapeptide, processes for preparation thereof and pharmaceutical compsns. containing it. EP 0011283 .
|
【8】
Arya, V.P.; Blancafort, P.; Castaner, J.; Serradell, M.N.; FK-156. Drugs Fut 1983, 8, 8, 667.
|
【9】
Hemmi, K.; Takeno, H.; Okada, S.; Nakaguchi, O.; Kitaura, Y.; Hashimoto, M.; Total synthesis of FK-156 isolated from a Streptomyces as an immunostimulating peptide: Application of a novel copper chelate amino protection. J Am Chem Soc 1981, 103, 7026. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
10101 |
Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene
|
501-53-1 |
C8H7ClO2 |
详情 | 详情
|
(E) |
36108 |
benzyl 1-hydrazinecarboxylate
|
5331-43-1 |
C8H10N2O2 |
详情 | 详情
|
(II) |
10892 |
(4R)-4-[3-[(4S)-2,5-Dioxo-1,3-oxazolan-4-yl]propyl]-1,3-oxazolane-2,5-dione
|
|
C9H10N2O6 |
详情 |
详情
|
(X) |
36102 |
(4R)-4-[((2S)-2-[[(2R)-2-(acetoxy)propanoyl]amino]propanoyl)amino]-5-(benzyloxy)-5-oxopentanoic acid
|
|
C20H26N2O8 |
详情 |
详情
|
(XXI) |
36109 |
benzyl 2-((2R,6S)-2,6-diamino-7-[2-[(benzyloxy)carbonyl]hydrazino]-7-oxoheptanoyl)-1-hydrazinecarboxylate
|
|
C23H30N6O6 |
详情 |
详情
|
(XXII) |
36110 |
(2S,6R)-2,6-diamino-7-[2-[(benzyloxy)carbonyl]hydrazino]-7-oxoheptanoic acid
|
|
C15H22N4O5 |
详情 |
详情
|
(XXIII) |
36111 |
(2S,6R)-2,6-bis[[(benzyloxy)carbonyl]amino]-7-[2-[(benzyloxy)carbonyl]hydrazino]-7-oxoheptanoic acid
|
|
C31H34N4O9 |
详情 |
详情
|
(XXIV) |
36112 |
benzyl 2-[(2R)-2-[[(benzyloxy)carbonyl]amino]-5-[(4S)-2,5-dioxo-1,3-oxazolidin-4-yl]pentanoyl]-1-hydrazinecarboxylate
|
|
C24H26N4O8 |
详情 |
详情
|
(XXV) |
36113 |
(2S,6R)-2-amino-6-[[(benzyloxy)carbonyl]amino]-7-[2-[(benzyloxy)carbonyl]hydrazino]-7-oxoheptanoic acid
|
|
C23H28N4O7 |
详情 |
详情
|
(XXVI) |
20436 |
glycine
|
56-40-6 |
C2H5NO2 |
详情 | 详情
|
(XXVII) |
36114 |
2-[((2S,6R)-2-amino-6-[[(benzyloxy)carbonyl]amino]-7-[2-[(benzyloxy)carbonyl]hydrazino]-7-oxoheptanoyl)amino]acetic acid
|
|
C25H31N5O8 |
详情 |
详情
|
(XXVIII) |
36115 |
(4R,7S,10R,15S)-10-[(benzyloxy)carbonyl]-15-((4R)-4-[[(benzyloxy)carbonyl]amino]-5-[2-[(benzyloxy)carbonyl]hydrazino]-5-oxopentyl)-4,7-dimethyl-2,5,8,13,16-pentaoxo-3-oxa-6,9,14,17-tetraazanonadecan-19-oic acid
|
|
C45H55N7O15 |
详情 |
详情
|
(XXIX) |
36116 |
(4R,7S,10R,15S)-15-[(4R)-4-amino-5-hydrazino-5-oxopentyl]-10-carboxy-4,7-dimethyl-2,5,8,13,16-pentaoxo-3-oxa-6,9,14,17-tetraazanonadecan-19-oic acid
|
|
C22H37N7O11 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(A) The reaction of 5-(2-chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2-thione (I) with glycine (A) by means of Na2CO3 in refluxing ethanol-water gives 2-carboxymethylamino-7-nitro-5-(2-chlorophenyl)-3H-1,4-benzodiazepine (II), which is cyclized by means of dicyclohexylcarbodiimide in methylene chloride to afford 8-nitro-(2-chlorophenyl)-1,2-dihydro-1H,4H-imidazo[1,2-a][1,4]benzodiazepin-1-one (III). The reaction of (III) with dimethylformamide diethylacetal (B) by means of triethylamine in benzene yields 8-nitro-2-(dimethylaminomethylene)-6-(2-chlorophenyl)-1,2-dihydro-1H,4H-imidazo[1,2a][1,4]benzodiazepin-1-one (IV), which is treated with N-methylpiperazine (C) in refluxing toluene to produce 8-nitro-(2-chlorophenyl)-2-(N-methylpiperazin-1-ylmethylene)-1,2-dihydro-1H,4H-imidazo [1,2-a][1,4]benzodiazepin-1-one (V). This compound is finally treated with methanesulfonic acid.
【1】
Taylor, J.B.; Harrison D.R.; 1,2-Dihydro-6-phenyl-1H,4H-imidazobenzodiazepin-1-ones. US 4044142 .
|
【2】
Ager, J.R.; et al.; Central nervous system activity of a novel class of annelated 1,4-benzodiazwpines, aminomethylene-2,4-dihydro-1H-imidazo[1,2-a][1,4]benzodiazepin-1-ones. J Med Chem 1977, 20, 8, 1035-41.
|
【3】
Thorpe, P.J.; Castaner, J.; Blancafort, P.; Serradell, M.N.; RU-31,158. Drugs Fut 1980, 5, 3, 144.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
40922 |
N,N'-dicyclohexylurea
|
2387-23-7 |
C13H24N2O |
详情 | 详情
|
(A) |
20436 |
glycine
|
56-40-6 |
C2H5NO2 |
详情 | 详情
|
(B) |
31457 |
N-(diethoxymethyl)-N,N-dimethylamine; diethoxy-N,N-dimethylmethanamine
|
1188-33-6 |
C7H17NO2 |
详情 | 详情
|
(I) |
32632 |
5-(2-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepine-2-thione
|
|
C15H10ClN3O2S |
详情 |
详情
|
(II) |
32633 |
2-[[5-(2-chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2-yl]amino]acetic acid
|
|
C17H13ClN4O4 |
详情 |
详情
|
(III) |
30373 |
6-(2-chlorophenyl)-8-nitro-2,4-dihydro-1H-imidazo[1,2-a][1,4]benzodiazepin-1-one
|
|
C17H11ClN4O3 |
详情 |
详情
|
(IV) |
32634 |
6-(2-chlorophenyl)-2-[(Z)-(dimethylamino)methylidene]-8-nitro-1H-imidazo[1,2-a][1,4]benzodiazepin-1(4H)-one
|
|
C20H16ClN5O3 |
详情 |
详情
|
(V) |
30375 |
6-(2-chlorophenyl)-2-[(Z)-(4-methyl-1-piperazinyl)methylidene]-8-nitro-1H-imidazo[1,2-a][1,4]benzodiazepin-1(4H)-one
|
|
C23H21ClN6O3 |
详情 |
详情
|
(C) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(II) The condensation of 3,4-dimethoxybenzaldehyde (I) with glycine (II) by means of KOH in hot methanol gives racemic threo-3-(3,4-dimethoxyphenyl)serine (III), which is acylated with N-(ethoxycarbonyl)phthalimide (IV) by means of Na2CO3 in water yielding the corresponding N-phthaloyl derivative (V). The reaction of (V) with AlCl3 and ethyl mercaptan in dichloromethane affords N-phthaloyl-3-(3,4-dihydroxyphenyl)serine (VI), which is deprotected with hydrazine in refluxing ethanol to racemic threo-3-(3,4-dihydroxyphenyl)serine (VII). The resolution of the racemic form (VII) is performed through its benzyloxy derivative.
【1】
Ohashi, N.; Nagata, S.; Ishimuzi, K.; Katsube, J. (Sumitomo Pharmaceuticals Co., Ltd.); Process for the production of optically active thr. EP 0024210; US 4319040 .
|
【2】
Ohashi, N.; Nagata, S.; Ishizumi, K. (Sumitomo Pharmaceuticals Co., Ltd.); Process for producing 3-(3,4-dihydroxyphenyl)serin. EP 0128684; US 4562263 .
|
【3】
Castaner, J.; Prous, J.; L-threo-DOPS. Drugs Fut 1987, 12, 5, 433.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18304 |
3,4-Dimethoxybenzaldehyde; Veratraldehyde
|
120-14-9 |
C9H10O3 |
详情 | 详情
|
(II) |
20436 |
glycine
|
56-40-6 |
C2H5NO2 |
详情 | 详情
|
(III) |
22983 |
3-hydroxy-3,4-dimethoxyphenylalanine
|
|
C11H15NO5 |
详情 |
详情
|
(IV) |
10283 |
ethyl 1,3-dioxo-1,3-dihydro-2H-isoindole-2-carboxylate; N-Carbethoxyphthalimide
|
22509-74-6 |
C11H9NO4 |
详情 | 详情
|
(V) |
22985 |
3-(3,4-dimethoxyphenyl)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-hydroxypropionic acid
|
|
C19H17NO7 |
详情 |
详情
|
(VI) |
22986 |
3-(3,4-dihydroxyphenyl)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-hydroxypropionic acid
|
|
C17H13NO7 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(XII) Several novel syntheses of 2-butyl-5-chloro-3H-imidazole-4-carbaldehyde (XI), a key intermediate in the synthesis of losartan, have been described:
1) Treatment of glycine methyl ester hydrochloride (I) with NaOH in methanol, followed by reaction with methyl pentanimidate (II), gives 2-butyl-4,5-dihydro-1H-imidazol-5-one (III), which is treated with POCl3 to give the 2-butyl-5-chloro-1H-imidazole (IV). Reaction of (IV) with POCl3 and DMF yields the enamine (V), which is finally hydrolyzed with water to 2-butyl-5-chloro-3H-imidazole-4-carbaldehyde (XI), the desired intemediate in the synthesis of losartan.
2) Imidazolinone (III) can also be obtained by cyclization of chloroacetic acid methyl ester (VI), chloroacetyl chloride (VII) or bromoacetyl bromide (VIII) with pentanamidine (IX) by means of NaOH in methanol.
3) Alternatively, imidazolinone (III) can be treated with dimethylformamide dimethylacetal in dichloromethane yielding the enamine (X), which is finally treated with POCl3 and hydrolyzed with water.
4) The reaction of glycine (XI) with methyl pentanimidate (II) in NaOH/MeOH gives amidine (XII), which, without isolation, is treated with POCl3 and DMF at 100 C for 2 h, and then hydrolyzed with water to give the desired 2-butyl-5-chloro-3H-imidazole-4-carbaldehyde.
Methyl pentanimidate (II) is obtained treating a solution of valeronitrile in MeOH with HCl gas followed by neutralization with aqueous KOH and extraction with Et2O.
【1】
Kohr, J.; Griffiths, G.J.; Imwinkelried, R.; Hauck, M.B.; Roten, C.A.; Stucky, G.C.; Novel syntheses of 2-butyl-5-chloro-3H-imidazole-4-carbaldehyde: A key intermediate for the synthesis of the angiotensin II antagonist losartan. J Org Chem 1999, 64, 22, 8084. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17568 |
methyl 2-aminoacetate
|
|
C3H7NO2 |
详情 |
详情
|
(II) |
34050 |
methyl pentanimidoate
|
|
C6H13NO |
详情 |
详情
|
(III) |
34051 |
2-butyl-3,5-dihydro-4H-imidazol-4-one
|
|
C7H12N2O |
详情 |
详情
|
(IV) |
34052 |
2-butyl-5-chloro-1H-imidazole
|
|
C7H11ClN2 |
详情 |
详情
|
(V) |
34053 |
N-[(2-butyl-5-chloro-4H-imidazol-4-ylidene)methyl]-N,N-dimethylamine; (2-butyl-5-chloro-4H-imidazol-4-ylidene)-N,N-dimethylmethanamine
|
|
C10H16ClN3 |
详情 |
详情
|
(VI) |
10257 |
methyl 2-chloroacetate; methyl chloroacetate
|
96-34-4 |
C3H5ClO2 |
详情 | 详情
|
(VII) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(VIII) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(IX) |
14576 |
pentanimidamide
|
109-51-3 |
C5H12N2 |
详情 | 详情
|
(X) |
34054 |
2-butyl-5-[(E)-(dimethylamino)methylidene]-3,5-dihydro-4H-imidazol-4-one
|
|
C10H17N3O |
详情 |
详情
|
(XI) |
13925 |
2-Butyl-4-chloro-1H-imidazole-5-carbaldehyde
|
83857-96-9 |
C8H11ClN2O |
详情 | 详情
|
(XII) |
20436 |
glycine
|
56-40-6 |
C2H5NO2 |
详情 | 详情
|
(XIII) |
34055 |
2-(pentanimidoylamino)acetic acid
|
|
C7H14N2O2 |
详情 |
详情
|
(XIV) |
13921 |
Pentanenitrile; n-Valeronitrile
|
110-59-8 |
C5H9N |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(VI) In a different method, N-phthaloylglycine (VII) was obtained by melting a mixture of phthalic anhydride (V) and glycine (VI). Subsequent chlorination of (VII) using SOCl2 provided acid chloride (VIII). Condensation of (VIII) with the sodium derivative of the tricarboxylate compound (IX) gave the keto triester (X). Hydrogenolysis of the benzyl ester groups of (X), followed by decarboxylation in refluxing toluene, gave rise to delta-phthalimidolevulinic acid (XI). This was finally hydrolyzed to the title compound upon refluxing with 7 N HCl.
【1】
Neuberger, A.; Scott, J.J.; The synhtesis of delta-succinamidolaevulic acid and related compounds. J Chem Soc 1954, 1820.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
11900 |
2-Benzofuran-1,3-dione;1,2-Benzenedicarboxylic Anhydride;1,2-BENZENE DICARBOXYLIC ACID ANHYDRIDE;1,2-BENZENEDICARBONIC ACID, ANHYDRIDE;1,3-DIOXOPHTHALAN;1,3-ISOBENZOFURANDIONE;o-phthalic anhydride; Phthalic anhydride |
85-44-9 |
C8H4O3 |
详情 | 详情
|
(VI) |
20436 |
glycine
|
56-40-6 |
C2H5NO2 |
详情 | 详情
|
(VII) |
10284 |
N-Phthaloylglycine; 2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid
|
4702-13-0 |
C10H7NO4 |
详情 | 详情
|
(VIII) |
10278 |
2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl chloride
|
6780-38-7 |
C10H6ClNO3 |
详情 | 详情
|
(IX) |
59145 |
tribenzyl 1,1,2-ethanetricarboxylate
|
|
C26H24O6 |
详情 |
详情
|
(X) |
59146 |
tribenzyl 4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-oxo-1,2,2-butanetricarboxylate
|
|
C36H29NO9 |
详情 |
详情
|
(XI) |
59147 |
5-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-4-oxopentanoic acid
|
|
C13H11NO5 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(I) The condensation of the labeled glycine (I) with phthalic anhydride (II) by heating at 160 C gives the labeled phthalimido acetic acid (III), which is treated with refluxing SOCl2 to yield the acyl chloride (IV). The condensation of (IV) with 3-iodopropionic acid ethyl ester (V) by means of the Zn/Cu couple and Pd(PPh3)4 in hot toluene affords the labeled 5-phthalimido-levulinate (VI), which is finally treated with refluxing 6N HCl to provide the target labeled aminolevulinic acid.
【1】
Iida, K.; Kajiwara, M.; Synthesis of 13C and 15N multilabeled 5-aminolevulinic acid. J Label Compd Radiopharm 2002, 45, 2, 139.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20436 |
glycine
|
56-40-6 |
C2H5NO2 |
详情 | 详情
|
(I) |
61588 |
GLYCINE-13C2-15N
|
|
C2H5NO2 |
详情 |
详情
|
(II) |
11900 |
2-Benzofuran-1,3-dione;1,2-Benzenedicarboxylic Anhydride;1,2-BENZENE DICARBOXYLIC ACID ANHYDRIDE;1,2-BENZENEDICARBONIC ACID, ANHYDRIDE;1,3-DIOXOPHTHALAN;1,3-ISOBENZOFURANDIONE;o-phthalic anhydride; Phthalic anhydride |
85-44-9 |
C8H4O3 |
详情 | 详情
|
(III) |
10284 |
N-Phthaloylglycine; 2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid
|
4702-13-0 |
C10H7NO4 |
详情 | 详情
|
(III) |
61589 |
2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid
|
|
C10H7NO4 |
详情 |
详情
|
(IV) |
10278 |
2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl chloride
|
6780-38-7 |
C10H6ClNO3 |
详情 | 详情
|
(IV) |
61590 |
2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl chloride
|
|
C10H6ClNO3 |
详情 |
详情
|
(V) |
61591 |
ethyl 3-iodopropanoate
|
|
C5H9IO2 |
详情 |
详情
|
(VI) |
59167 |
ethyl 5-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-4-oxopentanoate
|
|
C15H15NO5 |
详情 |
详情
|
(VI) |
61592 |
ethyl 5-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-4-oxopentanoate
|
|
C15H15NO5 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(II) The condensation of phthalic anhydride (I) with glycine (II) by heating at 160 C gives 2-phthalimidoacetic acid (III), which is treated with refluxing SOCl2 to yield the acetyl chloride (IV). The condensation of (IV) with Meldrum's acid (V) by means of pyridine in dichloromethane, followed by a treatment with refluxing ethanol, affords 4-phthalimidoaetoacetic acid ethyl ester (VI), which is condensed with 1-13C-labeled 2-bromoacetic acid ethyl ester (VII) by means of NaH in dimethoxyethane to provide labeled 2-(2-phthalimidoacetyl)succinic acid diethyl ester (VIII). Finally, this compound is treated with HCl in refluxing acetic acid to give the target labeled aminolevulinic acid.
【1】
Kurumaya, K.; Okazaki, T.; Seido, N.; Akasaka, Y.; Kawajiri, Y.; Kajiwara, M.; Kondo, M.; Facile synthesis of delta-aminolevulinic acid (ALA) regioselectively labeled with 13C and direct observation of enzymatic transformation from ALA to porphobilinogen (PBG). J Label Compd Radiopharm 1989, 27, 2, 217. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11900 |
2-Benzofuran-1,3-dione;1,2-Benzenedicarboxylic Anhydride;1,2-BENZENE DICARBOXYLIC ACID ANHYDRIDE;1,2-BENZENEDICARBONIC ACID, ANHYDRIDE;1,3-DIOXOPHTHALAN;1,3-ISOBENZOFURANDIONE;o-phthalic anhydride; Phthalic anhydride |
85-44-9 |
C8H4O3 |
详情 | 详情
|
(II) |
20436 |
glycine
|
56-40-6 |
C2H5NO2 |
详情 | 详情
|
(III) |
10284 |
N-Phthaloylglycine; 2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid
|
4702-13-0 |
C10H7NO4 |
详情 | 详情
|
(IV) |
10278 |
2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl chloride
|
6780-38-7 |
C10H6ClNO3 |
详情 | 详情
|
(V) |
14738 |
Meldrum's acid; 2,2-dimethyl-1,3-dioxane-4,6-dione;Malonic acid cyclic isopropylidene ester |
2033-24-1 |
C6H8O4 |
详情 | 详情
|
(VI) |
61596 |
ethyl 4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-oxobutanoate
|
|
C14H13NO5 |
详情 |
详情
|
(VII) |
16640 |
Ethyl 2-bromoacetate; Ethyl bromoacetate
|
105-36-2 |
C4H7BrO2 |
详情 | 详情
|
(VII) |
61597 |
ethyl 2-bromoacetate
|
|
C4H7BrO2 |
详情 |
详情
|
(VIII) |
61598 |
diethyl 2-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl]succinate
|
|
C18H19NO7 |
详情 |
详情
|
(VIII) |
64690 |
diethyl 2-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl]succinate
|
|
C18H19NO7 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(II) The condensation of phthalic anhydride (I) with 1-13C-labeled glycine (II) by heating at 160 C gives 2-phthalimidoacetic acid (III), which is treated with refluxing SOCl2 to yield the acetyl chloride (IV). The condensation of (IV) with Meldrum's acid (V) by means of pyridine in dichloromethane, followed by a treatment with refluxing ethanol affords 4-phthalimidoaetoacetic acid ethyl ester (VI). This compound is condensed with 2-bromoacetic acid ethyl ester (VII) by means of NaH in dimethoxyethane to provide labeled 2-(2-phthalimidoacetyl)succinic acid diethyl ester (VIII). Finally, the compound is treated with HCl in refluxing acetic acid to give the target labeled aminolevulinic acid.
【1】
Kurumaya, K.; Okazaki, T.; Seido, N.; Akasaka, Y.; Kawajiri, Y.; Kajiwara, M.; Kondo, M.; Facile synthesis of delta-aminolevulinic acid (ALA) regioselectively labeled with 13C and direct observation of enzymatic transformation from ALA to porphobilinogen (PBG). J Label Compd Radiopharm 1989, 27, 2, 217. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11900 |
2-Benzofuran-1,3-dione;1,2-Benzenedicarboxylic Anhydride;1,2-BENZENE DICARBOXYLIC ACID ANHYDRIDE;1,2-BENZENEDICARBONIC ACID, ANHYDRIDE;1,3-DIOXOPHTHALAN;1,3-ISOBENZOFURANDIONE;o-phthalic anhydride; Phthalic anhydride |
85-44-9 |
C8H4O3 |
详情 | 详情
|
(II) |
20436 |
glycine
|
56-40-6 |
C2H5NO2 |
详情 | 详情
|
(II) |
61599 |
glycine
|
|
C2H5NO2 |
详情 |
详情
|
(III) |
10284 |
N-Phthaloylglycine; 2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid
|
4702-13-0 |
C10H7NO4 |
详情 | 详情
|
(III) |
61600 |
2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid
|
|
C10H7NO4 |
详情 |
详情
|
(IV) |
10278 |
2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl chloride
|
6780-38-7 |
C10H6ClNO3 |
详情 | 详情
|
(IV) |
61627 |
2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl chloride
|
|
C10H6ClNO3 |
详情 |
详情
|
(V) |
14738 |
Meldrum's acid; 2,2-dimethyl-1,3-dioxane-4,6-dione;Malonic acid cyclic isopropylidene ester |
2033-24-1 |
C6H8O4 |
详情 | 详情
|
(VI) |
61596 |
ethyl 4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-oxobutanoate
|
|
C14H13NO5 |
详情 |
详情
|
(VI) |
61628 |
ethyl 4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-oxobutanoate
|
|
C14H13NO5 |
详情 |
详情
|
(VII) |
16640 |
Ethyl 2-bromoacetate; Ethyl bromoacetate
|
105-36-2 |
C4H7BrO2 |
详情 | 详情
|
(VIII) |
61629 |
diethyl 2-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl]succinate
|
|
C18H19NO7 |
详情 |
详情
|
(VIII) |
64690 |
diethyl 2-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl]succinate
|
|
C18H19NO7 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(II) The condensation of phthalic anhydride (I) with glycine (II) by heating at 160 C gives 2-phthalimidoacetic acid (III), which is treated with refluxing SOCl2 to yield the acetyl chloride (IV). The condensation of (IV) with Meldrum's acid (V) by means of pyridine in dichloromethane, followed by a treatment with refluxing ethanol affords 4-phthalimidoaetoacetic acid ethyl ester (VI). This compound is condensed with 2-13C-labeled 2-bromoacetic acid ethyl ester (VII) by means of NaH in dimethoxyethane to provide labeled 2-(2-phthalimidoacetyl)succinic acid diethyl ester (VIII). Finally, this compound is treated with HCl in refluxing acetic acid to give the target labeled aminolevulinic acid.
【1】
Kurumaya, K.; Okazaki, T.; Seido, N.; Akasaka, Y.; Kawajiri, Y.; Kajiwara, M.; Kondo, M.; Facile synthesis of delta-aminolevulinic acid (ALA) regioselectively labeled with 13C and direct observation of enzymatic transformation from ALA to porphobilinogen (PBG). J Label Compd Radiopharm 1989, 27, 2, 217. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11900 |
2-Benzofuran-1,3-dione;1,2-Benzenedicarboxylic Anhydride;1,2-BENZENE DICARBOXYLIC ACID ANHYDRIDE;1,2-BENZENEDICARBONIC ACID, ANHYDRIDE;1,3-DIOXOPHTHALAN;1,3-ISOBENZOFURANDIONE;o-phthalic anhydride; Phthalic anhydride |
85-44-9 |
C8H4O3 |
详情 | 详情
|
(II) |
20436 |
glycine
|
56-40-6 |
C2H5NO2 |
详情 | 详情
|
(III) |
10284 |
N-Phthaloylglycine; 2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid
|
4702-13-0 |
C10H7NO4 |
详情 | 详情
|
(IV) |
10278 |
2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl chloride
|
6780-38-7 |
C10H6ClNO3 |
详情 | 详情
|
(V) |
14738 |
Meldrum's acid; 2,2-dimethyl-1,3-dioxane-4,6-dione;Malonic acid cyclic isopropylidene ester |
2033-24-1 |
C6H8O4 |
详情 | 详情
|
(VI) |
61596 |
ethyl 4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-oxobutanoate
|
|
C14H13NO5 |
详情 |
详情
|
(VII) |
16640 |
Ethyl 2-bromoacetate; Ethyl bromoacetate
|
105-36-2 |
C4H7BrO2 |
详情 | 详情
|
(VII) |
61630 |
ethyl 2-bromoacetate
|
|
C4H7BrO2 |
详情 |
详情
|
(VIII) |
61631 |
diethyl 2-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl]succinate
|
|
C18H19NO7 |
详情 |
详情
|
(VIII) |
64690 |
diethyl 2-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl]succinate
|
|
C18H19NO7 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(II) The condensation of phthalic anhydride (I) with glycine (II) by heating at 160 C gives 2-phthalimidoacetic acid (III), which is treated with refluxing SOCl2 to yield the acetyl chloride (IV). The condensation of (IV) with 2-13C-labeled Meldrum's acid (V) by means of pyridine in dichloromethane, followed by a treatment with refluxing ethanol affords 4-phthalimidoaetoacetic acid ethyl ester (VI). This compound is condensed with 2-bromoacetic acid ethyl ester (VII) by means of NaH in dimethoxyethane to provide labeled 2-(2-phthalimidoacetyl)succinic acid diethyl ester (VIII). Finally, the ester is treated with HCl in refluxing acetic acid to give the target labeled aminolevulinic acid.
【1】
Kurumaya, K.; Okazaki, T.; Seido, N.; Akasaka, Y.; Kawajiri, Y.; Kajiwara, M.; Kondo, M.; Facile synthesis of delta-aminolevulinic acid (ALA) regioselectively labeled with 13C and direct observation of enzymatic transformation from ALA to porphobilinogen (PBG). J Label Compd Radiopharm 1989, 27, 2, 217. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11900 |
2-Benzofuran-1,3-dione;1,2-Benzenedicarboxylic Anhydride;1,2-BENZENE DICARBOXYLIC ACID ANHYDRIDE;1,2-BENZENEDICARBONIC ACID, ANHYDRIDE;1,3-DIOXOPHTHALAN;1,3-ISOBENZOFURANDIONE;o-phthalic anhydride; Phthalic anhydride |
85-44-9 |
C8H4O3 |
详情 | 详情
|
(II) |
20436 |
glycine
|
56-40-6 |
C2H5NO2 |
详情 | 详情
|
(III) |
10284 |
N-Phthaloylglycine; 2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid
|
4702-13-0 |
C10H7NO4 |
详情 | 详情
|
(IV) |
10278 |
2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl chloride
|
6780-38-7 |
C10H6ClNO3 |
详情 | 详情
|
(V) |
14738 |
Meldrum's acid; 2,2-dimethyl-1,3-dioxane-4,6-dione;Malonic acid cyclic isopropylidene ester |
2033-24-1 |
C6H8O4 |
详情 | 详情
|
(V) |
61632 |
2,2-dimethyl-1,3-dioxane-4,6-dione
|
|
C6H8O4 |
详情 |
详情
|
(VI) |
61596 |
ethyl 4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-oxobutanoate
|
|
C14H13NO5 |
详情 |
详情
|
(VI) |
61633 |
ethyl 4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-oxobutanoate
|
|
C14H13NO5 |
详情 |
详情
|
(VII) |
16640 |
Ethyl 2-bromoacetate; Ethyl bromoacetate
|
105-36-2 |
C4H7BrO2 |
详情 | 详情
|
(VIII) |
61634 |
diethyl 2-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl]succinate
|
|
C18H19NO7 |
详情 |
详情
|
(VIII) |
64690 |
diethyl 2-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl]succinate
|
|
C18H19NO7 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(II) Reaction of glycine (II) with phthalic anhydride (I) in a microwave oven gave phthaloylglycine (III). Subsequent condensation with phenylamidoxime (IV) in the presence of DCC in dimethoxyethane afforded the O-acyl intermediate (V), which on heating cyclized to the title oxadiazole.
【1】
Antunes, R.; Batista, H.; Srivastava, R.M.; Thomas, G.; Araujo, C.C.; New phthalimide derivatives with potent analgesic activity: II. Bioorg Med Chem Lett 1998, 8, 21, 3071.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11900 |
2-Benzofuran-1,3-dione;1,2-Benzenedicarboxylic Anhydride;1,2-BENZENE DICARBOXYLIC ACID ANHYDRIDE;1,2-BENZENEDICARBONIC ACID, ANHYDRIDE;1,3-DIOXOPHTHALAN;1,3-ISOBENZOFURANDIONE;o-phthalic anhydride; Phthalic anhydride |
85-44-9 |
C8H4O3 |
详情 | 详情
|
(II) |
20436 |
glycine
|
56-40-6 |
C2H5NO2 |
详情 | 详情
|
(III) |
11284 |
(6aR,9R,10aR)-7-Allyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxylic acid
|
|
C18H20N2O2 |
详情 |
详情
|
(IV) |
20438 |
N'-hydroxybenzenecarboximidamide
|
613-92-3 |
C7H8N2O |
详情 | 详情
|
(V) |
20439 |
2-[2-([[(Z)-amino(phenyl)methylidene]amino]oxy)-2-oxoethyl]-1H-isoindole-1,3(2H)-dione
|
|
C17H13N3O4 |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(III) The cyclic peptide precursor (XIV) was prepared by solid-phase synthesis on a preformed HMPB-MBHA resin. Attachment of N-Fmoc-glycine (I) to the resin by means of DCC and DMAP afforded resin (II). The Fmoc protecting group was then removed with piperidine in DMF, yielding the glycine-bound resin (III). Further couplings with the following protected amino acids: N-Fmoc-3-(aminomethyl)-5-nitrobenzoic acid (IV), N-Fmoc-L-tyrosine(O-t-butyl) (VI) and N-Fmoc-glycine (I), followed by Fmoc deprotection cycles, produced in turn the peptide resins (V), (VII) and (VIII). To peptide resin (VIII) was then coupled N-Fmoc-L-aspartic acid gamma-t-butyl ester (IX), yielding resin (X). Peptide (XI) was then liberated from the resin by means of 1% trifluoroacetic acid in CH2Cl2. The Fmoc group was subsequently removed by treatment with diethylamine in acetonitrile, giving (XII).
【1】
Park, H.S.; et al.; Protein surface recognition by synthetic receptors: A route to novel submicromolar inhibitors for alpha-chymotrypsin. J Am Chem Soc 1999, 121, 1, 8.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I),(II) |
42131 |
2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]acetic acid
|
29022-11-5 |
C17H15NO4 |
详情 | 详情
|
(X),(XI) |
47339 |
2-([3-[(4S,10S)-4-[4-(tert-butoxy)benzyl]-10-[2-(tert-butoxy)-2-oxoethyl]-14-(9H-fluoren-9-yl)-3,6,9,12-tetraoxo-13-oxa-2,5,8,11-tetraazatetradec-1-yl]-5-nitrobenzoyl]amino)acetic acid
|
|
C48H54N6O13 |
详情 |
详情
|
(III) |
20436 |
glycine
|
56-40-6 |
C2H5NO2 |
详情 | 详情
|
(IV) |
47335 |
3-([[(9H-fluoren-9-ylmethoxy)carbonyl]amino]methyl)-5-nitrobenzoic acid
|
|
C23H18N2O6 |
详情 |
详情
|
(V) |
47336 |
2-[[3-(aminomethyl)-5-nitrobenzoyl]amino]acetic acid
|
|
C10H11N3O5 |
详情 |
详情
|
(VI) |
18858 |
(2S)-3-[4-(tert-butoxy)phenyl]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]propionic acid
|
|
C28H29NO5 |
详情 |
详情
|
(VII) |
47337 |
2-([3-[([(2S)-2-amino-3-[4-(tert-butoxy)phenyl]propanoyl]amino)methyl]-5-nitrobenzoyl]amino)acetic acid
|
|
C23H28N4O7 |
详情 |
详情
|
(VIII) |
47338 |
2-([3-[([(2S)-2-[(2-aminoacetyl)amino]-3-[4-(tert-butoxy)phenyl]propanoyl]amino)methyl]-5-nitrobenzoyl]amino)acetic acid
|
|
C25H31N5O8 |
详情 |
详情
|
(IX) |
22260 |
(2S)-4-(tert-butoxy)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-4-oxobutyric acid
|
|
C23H25NO6 |
详情 |
详情
|
(XII) |
47340 |
2-[(3-[(4S,10S)-10-amino-4-[4-(tert-butoxy)benzyl]-14,14-dimethyl-3,6,9,12-tetraoxo-13-oxa-2,5,8-triazapentadec-1-yl]-5-nitrobenzoyl)amino]acetic acid
|
|
C33H44N6O11 |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(III) Reaction of methyl 2,3,4-tri-O-acetyl-beta-D-glucuronyl-3-nitrobenzyl alcohol (I) with N,N'-disuccinimidyl carbonate affords the mixed carbonate ester (II), which is further coupled to glycine (III), producing carbamate (IV). Alcoholysis of (IV) with NaOMe in MeOH yields the deacetylated conjugate (V). This is then activated as the pentafluorophenyl ester (VI) upon treatment with pentafluorophenol and DCC.
【1】
Rawale, S.; Hrihorczuk, L.M.; Wei, W.-Z.; Zemlicka, J.; Synthesis and biological activity of the prodrug of class I major histocompatibility peptide GILGFVFTL activated by Beta-glucuronidase. J Med Chem 2002, 45, 4, 937.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
65153 |
methyl (2S,3R,4S,5R,6S)-3,4,5-tris(acetyloxy)-6-[4-(hydroxymethyl)-2-nitrophenoxy]tetrahydro-2H-pyran-2-carboxylate
|
|
C20H23NO13 |
详情 |
详情
|
(II) |
65155 |
methyl (2S,3R,4S,5R,6S)-3,4,5-tris(acetyloxy)-6-{4-[({[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl}oxy)methyl]-2-nitrophenoxy}tetrahydro-2H-pyran-2-carboxylate
|
|
C25H26N2O17 |
详情 |
详情
|
(III) |
20436 |
glycine
|
56-40-6 |
C2H5NO2 |
详情 | 详情
|
(IV) |
65156 |
2-({[(3-nitro-4-{[(2S,3R,4S,5R,6S)-3,4,5-tris(acetyloxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-2-yl]oxy}benzyl)oxy]carbonyl}amino)acetic acid
|
|
C23H26N2O16 |
详情 |
详情
|
(V) |
65154 |
2-({[(3-nitro-4-{[(2S,3R,4S,5S,6S)-3,4,5-trihydroxy-6-(methoxycarbonyl)tetrahydro-2H-pyran-2-yl]oxy}benzyl)oxy]carbonyl}amino)acetic acid
|
|
C17H20N2O13 |
详情 |
详情
|
(VI) |
65157 |
methyl (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(2-nitro-4-{[({[2-oxo-2-(2,3,4,5,6-pentafluorophenoxy)ethyl]amino}carbonyl)oxy]methyl}phenoxy)tetrahydro-2H-pyran-2-carboxylate
|
|
C23H19F5N2O13 |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(II) Cyclization of 4-phenoxyphthalic acid (I) with glycine (II) at 215 °C gives the phthalimide (III), which by esterification with MeOH and H2SO4 at reflux yields the methyl ester (IV). Subsequent rearrangement of the phthalimidoacetate (IV) by means of Na in BuOH at 97 °C, followed by flash chromatography provides the isoquinoline-2-carboxylate (V). Bromination of compound (V) using POBr3 and NaHCO3 in acetonitrile leads to butyl 8-bromo-3-hydroxy-6-phenoxyisoquinoline-2-carboxylate (VI), which by hydrolysis with NaOH in refluxing H2O/EtOH affords the carboxylic acid (VII). Substitution of bromine in intermediate (VII) using MeI and BuLi in THF at –78 °C, followed by alkylation with PhCH2Br by means of K2CO3 in refluxing acetone yields the 2-methyl isoquinoline (VIII). Ester hydrolysis of compound (VIII) using KOH in MeOH gives the corresponding carboxylic acid (IX), which is then activated with i-BuOCOCl and Et3N in CH2Cl2, followed by condensation with benzyl glycinate hydrochloride (X) to yield the benzyl ester (XI). Finally, compound (XI) is debenzylated with H2 over Pd/C in EtOAc/MeOH .
【1】
Arend, M.P., Flippin, L.A., Du, X., Ho, W.-B., Turtle, E.D., Guenzler-Pukall, V. (FibroGen, Inc.). Nitrogen-containing heteroaryl compounds and their use in increasing endogenous erythropoietin. WO 2004108681. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
67865 |
4-phenoxyphthalic acid |
|
C14H10O5 |
详情 | 详情
|
(II) |
20436 |
glycine
|
56-40-6 |
C2H5NO2 |
详情 | 详情
|
(III) |
67866 |
2-(1,3-dioxo-5-phenoxyisoindolin-2-yl)acetic acid |
|
C16H11NO5 |
详情 | 详情
|
(IV) |
67867 |
methyl 2-(1,3-dioxo-5-phenoxyisoindolin-2-yl)acetate |
|
C17H13NO5 |
详情 | 详情
|
(V) |
67868 |
butyl 1,4-dihydroxy-6-phenoxyisoquinoline-3-carboxylate |
|
C20H19NO5 |
详情 | 详情
|
(VI) |
67869 |
butyl 1-bromo-4-hydroxy-6-phenoxyisoquinoline-3-carboxylate |
|
C20H18BrNO4 |
详情 | 详情
|
(VII) |
67870 |
1-bromo-4-hydroxy-6-phenoxyisoquinoline-3-carboxylic acid |
|
C16H10BrNO4 |
详情 | 详情
|
(VIII) |
67871 |
benzyl 4-(benzyloxy)-1-methyl-6-phenoxyisoquinoline-3-carboxylate |
|
C31H25NO4 |
详情 | 详情
|
(IX) |
67872 |
4-(benzyloxy)-1-methyl-6-phenoxyisoquinoline-3-carboxylic acid |
|
C21H21NO4 |
详情 | 详情
|
(X) |
67873 |
benzyl 2-aminoacetate hydrochloride |
|
C9H11NO2.HCl |
详情 | 详情
|
(XI) |
67874 |
benzyl 2-(4-(benzyloxy)-1-methyl-6-phenoxyisoquinoline-3-carboxamido)acetate |
|
C33H28N2O5 |
详情 | 详情
|
合成路线15
该中间体在本合成路线中的序号:
(II) Condensation of 5-bromophthalide (XXIII) with phenol (XIII) by means of K2CO3, CuBr and acetylacetone in DMF gives 5-phenoxyphthalide (XXIV), which is submitted to lactone ring opening using SOCl2, Ph3PCl2, B(OMe)3 and K2CO3 in refluxing toluene to yield 2-(chloro-methyl)-4-phenoxybenzoyl chloride (XXV). Esterification of acid chloride (XXV) with MeOH at 50 °C provides the methyl ester (XXVI), which is then condensed with methyl N-tosylglycinate (XXVII) in the presence of K2CO3 and NaI in DMF at 50 °C to afford the N-substituted amino ester (XXVIII). Cyclization of diester (XXVIII) with NaOMe in MeOH leads to methyl 4-hydroxy-7-phenoxyisoquinoline-3-carboxylate (XXIX), which is submitted to Mannich reaction with bis(dimethylamino)methane (XXX) by means of AcOH at 57 °C to provide the 1-(dimethylaminomethyl)isoquinoline derivative (XXXI). Treatment of compound (XXXI) with Ac2O at 103 °C, followed by selective hydrolysis of the phenolic acetate with morpholine leads to methyl 1-(acetoxymethyl)-4-hydroxy-7-phenoxyisoquinoline-3-carboxylate (XXXII). Hydrogenolysis of benzylic acetate (XXXII) in the presence of Pd/C and Na2CO3 in EtOAc yields methyl 4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carboylate (XX), which is finally condensed with glycine (II) by means of NaOMe in MeOH at 110 °C .
【1】
Thompson, M.D., Park, J.M., Arend, M.P. (FibroGen, Inc.). Process for making isoquinoline compounds. CN 103435546; WO 2014014834. |
【2】
Witschi, C., Park, J.M., Thompson, M.D., Martinelli, M.J., Yeowell, D.A.,Arend, M.P. (FibroGen, Inc.). Crystalline forms of a prolyl hydroxylase inhibitor. WO 2014014835, US 2014024675. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
20436 |
glycine
|
56-40-6 |
C2H5NO2 |
详情 | 详情
|
(XIII) |
23540 |
Phenol
|
108-95-2 |
C6H6O |
详情 | 详情
|
(XX) |
67882 |
methyl 4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carboxylate |
|
C18H15NO4 |
详情 | 详情
|
(XXIII) |
33229 |
5-bromophthalide; 5-bromo-2-benzofuran-1(3H)-one
|
64169-34-2 |
C8H5BrO2 |
详情 | 详情
|
(XXIV) |
67885 |
5-phenoxyphthalide |
57830-14-5 |
C14H10O3 |
详情 | 详情
|
(XXV) |
67886 |
2-(chloromethyl)-4-phenoxybenzoyl chloride |
|
C14H10Cl2O2 |
详情 | 详情
|
(XXVI) |
67887 |
methyl 2-(chloromethyl)-4-phenoxybenzoate |
|
C15H13ClO3 |
详情 | 详情
|
(XXVII) |
57744 |
methyl 2-{[(4-methylphenyl)sulfonyl]amino}acetate
|
2645-02-5 |
C10H13NO4S |
详情 | 详情
|
(XXVIII) |
67888 |
methyl 2-((N-(2-methoxy-2-oxoethyl)-4-methylphenylsulfonamido)methyl)-4-phenoxybenzoate |
|
C25H25NO7S |
详情 | 详情
|
(XXIX) |
67889 |
methyl 4-hydroxy-7-phenoxyisoquinoline-3-carboxylate |
|
C17H13NO4 |
详情 | 详情
|
(XXX) |
14349 |
N,N,N,N-tetramethylmethanediamine; tetramethylmethylenediamine;bis(dimethylamino)methane; N-[(dimethylamino)methyl]-N,N-dimethylamine |
51-80-9 |
C5H14N2 |
详情 | 详情
|
(XXXI) |
67890 |
methyl 1-((dimethylamino)methyl)-4-hydroxy-7-phenoxyisoquinoline-3-carboxylate |
|
C20H20N2O4 |
详情 | 详情
|
(XXXII) |
67891 |
methyl 1-(acetoxymethyl)-4-hydroxy-7-phenoxyisoquinoline-3-carboxylate |
|
C20H17NO6 |
详情 | 详情
|
合成路线16
该中间体在本合成路线中的序号:
(II) Condensation of 2,5-dichlorobenzoyl chloride (I) with glycine (II) in the presence of NaOH in H2O/THF gives 2-(2,5-dichlorobenzoylamino) acetic acid (III), which then couples with the 1,3,2-benzodioxaborolyl butanamine derivative (IV) by means of TBTU and DIEA in DMF to yield peptide (V). O-Deprotection of 1,3,2-benzodioxaborolane (V) by means of HCl and 2-methylisopropyl boronic acid in methanol/hexane affords boroxin derivative (VI), which is finally esterified with citric acid (VII) in THF or MIBK or acetonitrile or 2-Me-THF or acetone or EtOAc .
【1】
Elliott, E.L., Ferdous, A.J., Kaufman, M.J. et al. (Millennium Pharmaceuticals,
Inc.). Boronate ester compounds and pharmaceutical compositions
thereof. CN 102066386, EP 2318419, JP 2011524902, US 2009325903,
WO 2009154737. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
68548 |
2,5-dichlorobenzoyl chloride;2,5-dichloro-benzoyl chlorid |
2905-61-5 |
C7H3Cl3O |
详情 | 详情
|
(II) |
20436 |
glycine
|
56-40-6 |
C2H5NO2 |
详情 | 详情
|
(III) |
68549 |
2-(2,5-dichlorobenzoylamino)acetic acid |
|
C9H7Cl2NO3 |
详情 | 详情
|
(IV) |
68550 |
(S)-3-methyl-1-((3aR,4R,6R,7aS)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butan-1-amine 2,2,2-trifluoroacetate |
|
C17H28BNO4.C2HF3O2 |
详情 | 详情
|
(V) |
68551 |
2,5-dichloro-N-(2-(((S)-3-methyl-1-((3aR,4R,6R,7aS)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-2-oxoethyl)benzamide |
|
C24H33BCl2N2O4 |
详情 | 详情
|
(VII) |
13856 |
2-Hydroxy-1,2,3-propanetricarboxylic acid; Citric acid
|
77-92-9 |
C6H8O7 |
详情 | 详情
|